Gallbladder disease: Cholelithiasis (gallstones) and cholecystitis have been reported with GLP-1 receptor agonist therapies and may also occur with rapid weight loss
"This can manifest in various ways, with an unpleasant, abnormal or altered taste sensation, and is often described as metallic." A spokesperson for Eli Lilly, maker of Trulicity, Mounjaro and Zepbound, told USA TODAY in an email: "Patient safety is Lillys top priority, and we take any reports regarding patient safety seriously
If you have diabetes and are taking insulin or sulfonylureas alongside GLP-1 therapy, be alert for hypoglycaemia symptoms and discuss dose adjustments with your healthcare team
Given its strong clinical data and proven results, Ozempic often emerges as the preferred choice for patients seeking significant and sustained weight loss as part of their overall wellness journey
Other questions also warrant further research, such as understanding why some patients with OSA dont fully respond to GLP-1 treatments